Kenvue (NYSE: KVUE) — Company Overview, News & Financial Data
Kenvue develops consumer health and wellness products, focusing on sustainability and innovation for everyday needs.

Kenvue
Kenvue is a consumer health company operating across self-care, skin health and beauty, and essential health segments. Headquartered in Skillman, New Jersey, the company manufactures and distributes personal care products, over-the-counter medicines, oral care treatments, and dermatologist-tested skincare solutions. Its brand portfolio includes Tylenol, Motrin, Zyrtec, Benadryl, Neutrogena, Aveeno, Listerine, Band-Aid, and Johnson's. Formed through a corporate separation from Johnson & Johnson, the enterprise delivers everyday health products to consumers across North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America, supported by dedicated research facilities and global supply networks.
Snapshot
Operations
Products and/or services of Kenvue
- Self Care & Pain Relief: Over-the-counter analgesics, fever reducers, and anti-inflammatory medications, primarily anchored by Tylenol and Motrin. Products include fixed-dose combinations such as acetaminophen and naproxen sodium formulations distributed globally through retail and pharmacy channels.
- Allergy & Respiratory Care: Over-the-counter antihistamines and allergy management products led by Zyrtec and Benadryl brands. Operations encompass oral tablets, liquid suspensions, and drug-free nasal mist allergen barrier sprays supplied across North American, European, and Asia-Pacific markets.
- Skin Health & Beauty: Dermatologist-recommended skin care, hair care, and topical treatments under brands including Neutrogena, Aveeno, OGX, and Rogaine. Offerings focus on moisturizing gels, hydro-boost hydrating serums, anti-aging creams, and topical minoxidil hair regrowth formulations.
- Oral Care Solutions: Antiseptic mouthwashes and oral rinse product lines marketed globally under the Listerine brand. Operations include alcohol-based and extra-mild antiseptic mouthwash formulations designed to reduce plaque, prevent gingivitis, and treat oral health conditions.
- Essential & First Aid Health: First aid supplies, wound treatment products, and specialty topicals sold under Band-Aid, Neosporin, and Polysporin brands. Products include adhesive bandages, antibiotic ointments, and healing dressings distributed to retail consumers and healthcare channels.
- Pediatric & Baby Care: Specialized infant and child personal care products distributed worldwide under Johnson's and Aveeno Baby brands. Offerings comprise tear-free shampoos, baby lotions, eczema relief creams, and gentle cleansers tailored for sensitive infant skin.
Kenvue executive team
- Kirk L. PerryCEO & Director
- Michael P. WondraschChief Technology & Data Officer
- Matthew OrlandoGeneral Counsel
- Carlton LawsonGroup President of Europe, Middle East & Africa
- Heather R. HowlettInterim CFO & Chief Accounting Officer
- Meredith StevensChief Operations Officer
- Caroline TillettChief Scientific Officer
- Sofya TsinisHead of Investor Relations
- Jonathan HalvorsonChief Digital & Marketing Officer
- Anil AgarwalHead of Total Rewards
Latest news about Kenvue
Kenvue reports 3.2% Q3 sales growth, EPS up 5%
United StatesKenvue loses appeal bid in Tylenol lawsuits
United StatesKimberly-Clark offers EU remedies for $40 billion Kenvue deal
United StatesKenvue declares $0.21 quarterly dividend
United StatesKenvue’s sales momentum pushes revenue to $3.96 billion
United StatesKenvue profitability rallies in Q1 as margins expand ahead of strategic deal
United States
Recent announcements
What Kenvue (KVUE) has told the market, newest first.
Dividend history
Dividends per share paid by Kenvue, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026(to date) | — | — | — | $0.8360 |
| FY2025 | — | — | — | $0.8260 |
| FY2024 | — | — | — | $0.8100 |
| FY2023 | — | — | — | $0.4000 |
Key financials
Reported results for Kenvue, in USD.
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 15.1B | 2.7B | 1.5B | |
| 15.5B | 1.8B | 1B | |
| 15.4B | 2.5B | 1.7B | |
| 15B | 2.7B | 2.1B |